Daily non-political popular news in brief.

Mice cloned from skin cells

Healthy and viable mice that survive until adulthood have, for the first time, been cloned from adult stem cells. The scientists used keratinocyte stem cells, which represent a new model system for cloning. Keratinocytes come from the skin, making them a particularly attractive stem cell source because of their ready accessibility. One day, they could be used to tailor therapies, as well as to better understand and treat diseases.

Read more »

Keywords: mice, cloned, skin, cells, cell

« Previous | Next »

Similar news on "Mice cloned from skin cells":

1. Mass. General researchers identify master cardiac stem cell
   11-22-2006 · EurekAlert!
   Researchers from the Massachusetts General Hospital Cardiovascular Research Center have discovered what appears to be a master cardiac stem cell, capable of differentiating into the three major cell types of the mammalian heart. In a report to appear in the journal Cell, receiving early online release, they describe identifying these progenitor cells in mice, cloning them from embryonic stem cells, and showing that cloned cells can differentiate into cardiac muscle, smooth muscle or endothelial cells.
   Similar news · Read more »
   
2. Cloned Mice Created From Fully Differentiated Cells, A Milestone In Cloning Research
   10-02-2006 · ScienceDaily
   New research dismisses the notion that adult stem cells are necessary for successful animal cloning, proving instead that cells that have completely evolved to a specific type not only can be used for cloning purposes, but they may be better and more efficient. As proof, researchers report they created two mouse pups from a type of blood cell that itself is incapable of dividing to produce a second generation of its own kind.
   Similar news · Read more »
   
3. Tumor-reactive T cells boosted by hematopoietic stem cell transplantation
   02-01-2007 · EurekAlert!
   Treatment for skin cancer by infusion of tumor-reactive T cells requires patients to be pre-treated with agents that transiently decrease the number of immune cells (nonmyeloablative agents). A study in mice now indicates that pre-treatment with more intense immune cell-depleting strategies (known as myeloablative strategies) and a hematopoietic stem cell transplant enables infused tumor-reactive CD8+ T cells to increase in number more than pre-treatment with nonmyeloablative agents, and this correlates with increased tumor regression.
   Similar news · Read more »
   
4. Scientists clone mice from adult skin stem cells
   02-12-2007 · EurekAlert!
   Using a nuclear transfer procedure, scientists at Rockefeller University and the Howard Hughes Medical Institute have, for the first time, shown reproducibly that mice can be cloned from adult stem cells.
   Similar news · Read more »
   
5. Immunosuppressive drugs are a double-edged sword to type 1 diabetics
   09-04-2007 · EurekAlert!
   Type 1 diabetes occurs when immune cells destroy pancreatic insulin producing beta-cells. It was hoped that islet transplantation would provide a cure for the disease, however, transplant success is short-lived and accompanied by significant side effects. New data indicate that the immunosuppressive drugs used to prevent islet transplant rejection suppress beta-cell regeneration in diabetic mice, raising the possibility that identifying immunosuppressive drugs that do not inhibit beta-cell regeneration might lead to successful regenerative islet transplantation.
   Similar news · Read more »
   
6. Replacing the cells lost in Parkinson disease
   12-03-2007 · EurekAlert!
   Parkinson disease is caused by the progressive degeneration of dopamine brain cells. Replacing these cells is considered a promising therapeutic strategy. Although DA cell-replacement therapy by transplantation of human fetal mesencephalic tissue has shown promise, limited tissue availability means other sources of these cells are needed. A recent study has described one new source for DA cells that provided marked benefit when transplanted into mice with a PD-like disease.
   Similar news · Read more »
   
7. T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells
   09-18-2007 · EurekAlert!
   Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia, according to researchers at Memorial Sloan-Kettering Cancer Center. By administering repeated doses of T cells designed to express an artificial receptor which recognizes human B cells, the researchers were able to eradicate cancer in 44 percent of mice bearing human ALL tumors.
   Similar news · Read more »
   
8. Signal protein shows promise for blocking tumor promoters in skin cells
   11-03-2006 · EurekAlert!
   A protein with the ironic name "Srcasm" can counteract the effects of tumor-promoting molecules in skin cells. Using animal models, the researchers discovered that Srcasm acts like a brake in epithelial cells, preventing uncontrolled cell growth caused by a family of proteins called Src kinases. This finding, published online in the Journal of Biological Chemistry, suggests a target for future gene therapy to treat skin, head, neck, colon and breast cancers.
   Similar news · Read more »
   
9. Pittsburgh-based team engineers muscle, bone cell differentiation with aid of ink-jet printer
   12-10-2006 · EurekAlert!
   A team of researchers from Carnegie Mellon University and the University of Pittsburgh has created and used an innovative ink-jet system to print "bio-ink" patterns that direct muscle-derived stem cells from adult mice to differentiate into both muscle cells and bone cells. The results, which could revolutionize the design of replacement body tissues, will be presented Sunday, Dec. 10 at the 46th annual meeting of the American Society for Cell Biology in San Diego.
   Similar news · Read more »
   
10. Scientists produce neurons from human skin
    02-22-2007 · EurekAlert!
    Scientists from Université Laval's Faculty of Medicine have succeeded in producing neurons in vitro using stem cells extracted from adult human skin. This is the first time such an advanced state of nerve cell differentiation has been achieved from human skin, according to lead researcher Professor François Berthod. This breakthrough could eventually lead to revolutionary advances in the treatment of neurodegenerative illnesses such as Parkinson's disease.
    Similar news · Read more »